8.05
price down icon4.17%   -0.35
after-market Dopo l'orario di chiusura: 7.81 -0.24 -2.98%
loading

Transcode Therapeutics Inc Borsa (RNAZ) Ultime notizie

pulisher
Jan 29, 2025

How Is The Market Feeling About TransCode Therapeutics? - Benzinga

Jan 29, 2025
pulisher
Jan 29, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jan 29, 2025
pulisher
Jan 28, 2025

Stock market news: TransCode Therapeutics +133.97%, Diginex +27.49% among top gainers during mid day trading - Business Upturn

Jan 28, 2025
pulisher
Jan 28, 2025

Are Investors Keen On Selling Holdings In GSK Plc ADR (NYSE: GSK)? - Stocks Register

Jan 28, 2025
pulisher
Jan 28, 2025

Dow Inc (NYSE: DOW) Is A Buzzing Hot Stock - Stocks Register

Jan 28, 2025
pulisher
Jan 28, 2025

Stock market today: Sentage Holdings +70.79%, Planet Image International +64.29% among top gainers in early trading - Business Upturn

Jan 28, 2025
pulisher
Jan 24, 2025

TransCode Therapeutics Shares Are Surging Today: What's Going On? - Benzinga

Jan 24, 2025
pulisher
Jan 23, 2025

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com UK

Jan 23, 2025
pulisher
Jan 16, 2025

Clinical Trials News Live Feed - StockTitan

Jan 16, 2025
pulisher
Jan 14, 2025

Transcode Therapeutics doses first patient in third cohort of Phase 1trial - TipRanks

Jan 14, 2025
pulisher
Jan 14, 2025

TransCode's TTX-MC138 Cancer Trial Advances: First Patient Dosed in Cohort 3 with Doubled Dose - StockTitan

Jan 14, 2025
pulisher
Jan 13, 2025

Transcode Therapeutics stock hits 52-week low at $3.20 - Investing.com India

Jan 13, 2025
pulisher
Jan 07, 2025

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements - PR Newswire

Jan 07, 2025
pulisher
Jan 07, 2025

TransCode Therapeutics Secures Nasdaq Listing Status After Meeting Critical Requirements - StockTitan

Jan 07, 2025
pulisher
Jan 04, 2025

SABBY MANAGEMENT, LLC Acquires Shares in TransCode Therapeutics Inc - GuruFocus.com

Jan 04, 2025
pulisher
Dec 29, 2024

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Short Interest Update - Defense World

Dec 29, 2024
pulisher
Dec 28, 2024

Financial Analysis: TransCode Therapeutics (NASDAQ:RNAZ) & Eliem Therapeutics (NASDAQ:ELYM) - Defense World

Dec 28, 2024
pulisher
Dec 23, 2024

HC Wainwright Has Optimistic Outlook of RNAZ FY2024 Earnings - Defense World

Dec 23, 2024
pulisher
Dec 21, 2024

Analysts Issue Forecasts for RNAZ Q1 Earnings - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

TransCode Therapeutics (NASDAQ:RNAZ) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

H.C. Wainwright raises TransCode Therapeutics target following SRC go-ahead for Cohort 3 - Investing.com

Dec 19, 2024
pulisher
Dec 18, 2024

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial - StreetInsider.com

Dec 18, 2024
pulisher
Dec 18, 2024

TransCode advances to third patient group in cancer trial - Investing.com India

Dec 18, 2024
pulisher
Dec 18, 2024

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 - Benzinga

Dec 18, 2024
pulisher
Dec 18, 2024

Transcode announces SRC approved third cohort in TTX-MC138 clinical trial - TipRanks

Dec 18, 2024
pulisher
Dec 18, 2024

RNAZTransCode Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

Crude Oil Gains Over 1%, General Mills Shares Fall - Benzinga

Dec 18, 2024
pulisher
Dec 13, 2024

Transcode Therapeutics stock hits 52-week low at $6.89 By Investing.com - Investing.com Canada

Dec 13, 2024
pulisher
Dec 04, 2024

TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 4 - MSN

Dec 04, 2024
pulisher
Dec 02, 2024

Janux, Vir stocks rally on positive data for Janux drug JANX007 - MSN

Dec 02, 2024
pulisher
Dec 02, 2024

TransCode Therapeutics Raises $8M in Private Placement - TipRanks

Dec 02, 2024
pulisher
Dec 02, 2024

Why TransCode Therapeutics (RNAZ) Stock Is Diving - Benzinga

Dec 02, 2024
pulisher
Nov 30, 2024

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split - The Manila Times

Nov 30, 2024
pulisher
Nov 29, 2024

TransCode Therapeutics Announces Reverse Stock Split - TipRanks

Nov 29, 2024
pulisher
Nov 29, 2024

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split to Meet Nasdaq Requirements | RNAZ Stock News - StockTitan

Nov 29, 2024
pulisher
Nov 28, 2024

TransCode Therapeutics announces $8M private offering - MSN

Nov 28, 2024
pulisher
Nov 28, 2024

Transcode Therapeutics issues 21.2M shares at 37.7c in private placement - Yahoo Finance

Nov 28, 2024
pulisher
Nov 28, 2024

TransCode secures $8 million in private placement - Investing.com India

Nov 28, 2024
pulisher
Nov 27, 2024

TransCode secures $8 million in private placement By Investing.com - Investing.com Australia

Nov 27, 2024
pulisher
Nov 27, 2024

TransCode Therapeutics, Inc. Announces $8 Million Private Placement - The Manila Times

Nov 27, 2024
pulisher
Nov 27, 2024

TransCode Therapeutics Secures $8M Private Placement, Issues 21.2M Shares | RNAZ Stock News - StockTitan

Nov 27, 2024
pulisher
Nov 26, 2024

TransCode Therapeutics, Inc. announced that it expects to receive $8 million in funding - Marketscreener.com

Nov 26, 2024
pulisher
Nov 26, 2024

Transcode Therapeutics announces 1-for-33 reverse stock split - Yahoo Finance

Nov 26, 2024
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):